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Asthma
' 'Asthma is a disease characterized by an
increased responsiveness of the trachea and
bronchi to various stimuli and manifested by a
wi despread narrowing of the airways that
changes in severity either spontaneously or in
response to therapy ." 1 The airway narrowing is
the end result of some combination of bronchial
muscle contraction , tissue inflammation , mucosa! edema, and luminal occlusion by cellular
debris and thickened secretions. During the last
decade, basic and applied research has shed
light on the physiology of the above changes
and has led to breakthroughs in therapy and the
more rational use of older and newer therapeutic agents, both separately and together.
Anatomy
The nasal passages , the oropharynx , and
the large , and some smaller, bronchi are extensively provided with a variety of receptors which
respond to temperature and irritating stimuli of
many types . The sensory signals emanating
from these receptors and others are transported
to the central nervous system by the vagus
nerve . The motor innervation of the bronchi is
Correspondence and reprint requests to Dr. Frederick
L. Glauser, Box 93, Medical College of Virginia, Ri chmond ,
VA 23298.

via the vagu s (cholinergic) and sympathetic
trunks (adrenergic} , both of which affect bronchomotor tone and secretions .
The epithelium of the intrathoracic airways
is covered with a "mucociliary blanket" which
facilitates the removal of particulate material ;
mucus is secreted by glandular epithelial cells .
Ciliated epithelium constantly moves the mucus
layer from peripheral to central airways , where
cough and expectoration eliminate the trapped
particles from the respiratory tract.
The multiple branch ing airways of the
lung , as far distal as the respiratory bronchiole,
are surrounded by bands of smooth muscle.
Proportionately greater amounts of muscle are
present in small bronchioles relative to large
and medium bronchi , and constriction of this
musculature can virtually occlude the airway .
Physiology
For any given flow rate, airways resistance
is dependent on the cross-sectional area
through which the gas is flowing, that is, the
larger the cross-sectional area the less the resistance and vice versa . Bronchial smooth muscle
contraction can markedly increase resistance
and this can be augmented by compromise of
the airway 's lumen by secretions, cells, and
other factors . Stimulation of the vagus nerve inMCV QUARTERLY 15(3):75-78, 1979
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duces bronchial smooth muscle contraction and
increases mucus secretion; sympathetic nerve
stimulation has a minimal opposite effect.
The relative "tone" of bronchial smooth
muscle, that is, the balance between muscle
contraction and relaxation, is controlled by the
intracellular ratio of the cyclic nucleotides. High
levels of cyclic adenosine monophosphate
(cAMP), induce relaxation, and conversely, increased levels of cyclic guanosine monophosphate (cGMP), induce contraction . Beta
agonists (isoproterenol, ephedrine, terbutaline,
among other drugs) appear to increase levels of
cAMP by stimulation of the enzyme adenylcyclase; corticosteroids may work in this fashion
as well. Methylxanthines, such as theophylline,
appear to prevent the breakdown of cAMP by
the enzyme phosphodiesterase and thus increase intracellular cAMP levels. Vagal stimulation in turn stimulates cAMP production, causing bronchoconstriction. 2

Pathophysiology
A large population of mast cells containing a variety of preformed "mediators" of hypersensitivity such as histamine are normally
found in the pulmonary interstitium; these cells
can synthesize from precursors other mediators
such as a slow-reacting substance of ananphylaxis (SRS-A). Both of these substances are
powerful bronchoconstrictors and may increase
cell membrane permeability, leading to mucosa!
edema. Additionally, these mediators increase
bronchial receptor sensitivity thus enhancing
neurogenic-induced bronchoconstriction. Other
mediators can cause inflammatory changes in
bronchi and attract and activate phagocytic
cells .
In extrinsic (allergic) asthma, mast cells
are sensitized by the attachment of antigen-specific lgE to their surface. If an appropriate antigen, such as pollen, fixes to the lgE, the various
mediators are released and/ or synthesized. 3
The rate of release/synthesis of mediators is
governed by the cAMP /cGMP ratio in the mastI
cell, and is thus subject to pharmacologic manipulation as has been discussed .
In other types of asthma (adult onset, intrinsic, aspirin-induced, and other forms) immunologic mechanisms do not play a dominant
role. Some suggested mechanisms causing the
airway hyperreactivity in these types of asthma
are:
76 /

B-adrenergic blockade: A decreased response to beta agonist drugs has been noted
in many asthmatics. It is possible that either
congenital defects in adenylcyclase production
or recurrent infections could induce this blockade.
Cholinergic dominance: This hypothesis
presupposes that the vagus nerve in the asthmatic is easily stimulated via the irritant receptors, leading to an enhanced bronchoconstrictive response (the ''twitchy vagus ' ' theory).
Cortical (emotional) components may act via
this pathway. Whether the vagus hyperreactivity
is a primary or secondary defect is in question.
Histamine, for example, increases irritant-receptor sensitivity and indirectly plays a role in vagally mediated bronchoconstriction .
Adrenergic amine deficiency: This hypothesis presupposes that in response to bronchoconstrictive stimuli, the adrenal medulla should
release additional epinephrine to partially modify this response (epinephrine acting as a beta
agonist). In the asthmatic, this response is impaired .
Smooth muscle abnormalities: Asthmatics
are known to have hypertrophied bronchial
musculature. Whether or not the muscle is also
innately more reactive is undecided .
Alpha-adrenergic hyperresponsiveness:
Some asthmatics have been shown to have an
exaggerated response to phenylephrine (a pure
alpha agonist) in organs other than the lung. It is
thus hypothesized that naturally occurring alpha
agonists (which increase mast cell and bronchial musculature intracellular cGMP) can induce bronchoconstriction .
Much is still to be learned about asthma.
Apparently, in all individuals, many factors play
a role in the pathogenesis of the disease, some
factors being dominant and others seeming less
significant. It is the clinician's responsibility to
determine in his patient which factors predominate and to tailor the treatment to these
findings.

Chronic Obstructive Pulmonary Disease
(COPD}
Emphysema and bronchitis constitute the
major disease entities which fall under the heading of Chronic Obstructive Pulmonary Disease
(COPD) . Although emphysema and bronchitis
will, for discussion purposes, be considered
separately, they occur concomitantly in most
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patients with COPD. Only a small percentage of
patie nts will have ''pure ' ' emphysema or
"pure" bronchitis.

" Class.ic" Findings in Far-Advanced Emphysema and Bronchitis
Emphysema is defined as destruction of
terminal alveolar capillary units with enlargement of the remaining air spaces. Etiologically,
it is causally related to cigarette smoking and
certain genetic disorders such as alpha 1 antitrypsin deficiency. In addition , there is some evidence that recurrent childhood pulmonary infections predispose smokers to emphysema.
The typical patient with far-advanced emphysema is 45 to 50 years of age and complai ns of dyspnea on mild exertion . Unless an
associated bronchitis is present, cough and
sputum production do not occur. Physical examination reveals a thin, cachectic patient with
an increased respiratory rate , using his or her
accessory muscles of respiration, an increase in
anteroposterior chest diameter, a tympanitic
chest percussion note , and decreased breath
sounds. Laboratory results are unremarkable
and the chest radiograph shows a vertical,
small heart with clear , hyperinflated lung fields;
· the EKG shows low voltage . Pulmonary function
tests are consistent with hyperinflation, decreased flow rates and diffusing capacity and
airway collapse . Mild hypoxemia (Pa0 2 > 55
torr) and normocapnea (PaC0 2 < 45 torr) are
common findings . Because of the labored
breathing and lack of cyanosis this type of patient has been termed the " pink puffer." As
lung destruction is the basic problem , most
therapeutic interventions are nonrewarding, but
teaching the patient to purse-lip breathe may
lessen the dyspnea and decrease the respiratory rate. 1
Chronic bronchitis is defined as an incre ase in sputum production two to three
months out of the year for two years in a row.
Patients with this condition usually are cigarette
smokers and/or have been exposed to industrial or air pollutants . Their chief complaint is a
cough productive of sputum , often described as
"a cigarette or morning cough ." The bronchitic
patient shows no evidence of weight loss , has a
normal chest AP diameter but may have, on
auscultation , wheezes , rhonchi , and early inspiratory rales . In addition, signs of right ventricu lar failure (jugular venous distention, hepa-
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Fig- Decreases in FEV 1 with age in nonsmokers, nonsusceptible smokers and susceptible smokers. This graph
depicts fall in FEV 1 in one particular susceptible smoker.
Other smokers will have different FEV 1 loss rates thus
reaching the " disability" line at different ages. See text for
explanation 'i_lnd discussion .

tomegaly, and peripheral edema) may be
present. Polycythemia and, in certain cases, either sputum or blood eosinophilia may be found
on routine laboratory analysis. Carbon dioxide
retention (PaC0 2 > 45 torr) and hypoxemia
(Pa0 2 < 55 torr) are found on arterial blood gas
analysis; pulmonary function tests reveal decreased flow rates which may respond to
bronchodilators. Chest radiography shows an
enlarged heart (mainly right ventricle) with increased bibasilar lung markings; the EKG may
show right ventricular hypertrophy. Because of
the cyanosis and the peripheral edema, these
patients have been termed "blue bloaters."
Treatment consists of antibiotics for recurrent
pulmonary infections, diuretics and digitalis for
the right heart failure and supplemental oxygen
for the hypoxemia.

Which Patients are at Risk of Developing
Symptomatic COPD?
The patient with far-advanced COPD responds poorly to treatment and the average life
expectancy after severe symptoms ensue is
3 Y2 to 5 years. 2 It would be advantageous to
predict which patients who smoke may develop
far-advanced disease as it is now known that ·
90% to 95% of all smokers are either not susceptible or minimally susceptible to the effect of
cigarette smoke; that is, life-long smoking does
not lead to symptomatic lung disease as described above. Most cigarette smokers have
normal or near normal FEV 1 s compared to age-
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matched nonsmoking controls (Line A, Figure). 3
A small percentage of patients, however, may
be susceptible to cigarette smoke and if FEV 1 s
are performed yearly (after age 40), there will
be a marked decline in the FEV, per year (Line
B, Figure) compared to normal values (Line A,
Figure). If these patients continue to smoke,
they will become symptomatic and disabled at a
relatively early age; if they stop smoking, the
FEV, decline will slow (Line C, Figure), but impaired pulmonary functions may be demonstrable, although the patient may be asymptomatic. If smoking is stopped late in the course
of the disease (that is, by the time disability occurs), although the FEV 1 decline will improve,
death will ensue in a relatively short period of
time (Line D, Figure). Therefore, FEV 1 s should
be performed yearly in all cigarette smokers >
40 years of age. If a marked loss of FEV 1 occurs (> 60 to 70cc/sec/yr), an aggressive approach to cessation of smoking should be instituted.

78 /

The Figure is modified by permission from the British
Medical Journal 1(1 : 1645-1648, 1977).
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Diseases Which Mimic Asthma and Chronic
Obstructive Pulmonary Disease (COPD)
GEORGE W. BURKE, Ill, M.D.
Assistant Professor of Medicine, and Director, Pulmonary Function Laboratories, Medical College of
Virginia, Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

The American Thoracic Society defines
asthma as a disease characterized by increased
responsiveness of the trachea and bronchi to
various stimuli and manifested by widespread
narrowing of the airways that changes in severity either spontaneously or as a result of therapy. 1 In this context asthma is a physiologic diagnosis. It is most often recognized when a
patient complains of episodic wheezing and
dyspnea and most often confirmed by the demonstration of variable airways obstruction on
spirometric testing .
Chronic bronchitis, on the other hand , is
characterized by excessive mucous secretion in
the bronchial tree and manifested by chronic or
recurrent productive cough present on most
days for a minimum of three months in the year
and for not less than two successive years. 1
Therefore, chronic bronchitis is a clinical diagnosis of exclusion, dependent upon a constellation of nonspecific symptoms. Emphysema is an alteration of the lung characterized
by an abnormal enlargement of air spaces distal
to the terminal bronchioles with destructive
changes of the alveolar wall. 1 Confirmation of
emphysema may be difficult because it is dependent upon lung anatomic findings or the appearance of obvious bullae on chest roentgenogram; moreover, it is recognized that chronic
bronchitis and emphysema occur together and
it may be difficult to predict which of these conditions is the dominant cause of chronic airways
Correspondence and reprint requests to Dr. George
W. Burke, 111 , Box 637, Medical College of Virginia, Richmond, VA 23298.

obstruction in an individual patient. To circumvent this difficulty, clinicians have preferred to ·
use the term "chronic obstructive lung disease"
(COPD) with the understanding that this term
implies the probable coexistence of both bronchitis and emphysema.
From a practical standpoi nt , clinicians
customarily respond to specific '' signals'' for
the detection of asthma or COPD. Common examples are a patient's complaint of wheezing
episodes, the demonstration of airways obstruction on spirometric testing , or detection of hypercapnia on arterial blood gas analysis. Appropriate interpretation of these signals requires not
only knowledge of the definitions of asthma and
COPD but also an awareness that there are numerous other diseases which can produce
these signals and thereby mimic asthma or
COPD.
The purpose of this report is to review and
demonstrate, by case reviews, diagnostic pitfalls in the approach to patients with diseases
which mimic asthma or COPD.
CASE 1 . A 20-year-old white female college student complained of an exacerbation of coughing,
mucopurulent sputum, and wheezing in April
1 9 7 4. She had experienced numerous identical
episodes since 1967 and had noted gradually
progressive exertional dyspnea. In 1 96 7, because of wheezing, a physician had diagnosed
"asthma" and prescribed a compound containing theophylline and glyceryl guaiacolate. She
was referred to an allergist who detected cutaneous hypersensitivity to multiple allergens and administered desensitization injection s. Despite
these interventions, her symptoms continued .
Past medical history revealed und iagnosed
chronic diahrrea during childhood . A physical ex-
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cystic fibrosis is the most common cause of
chronic airways obstru ction in young adults, 2 it
represents an important simulator of asthma
and COPD.

5-6-74
Fig 1-Posteroanterior chest roentgenogram of case 1
showing faint reticular densities in all lung fields and increased subcardi ac air.

amination revealed a well-developed and wellnourished fema le. There were inspiratory crackles in the upper lung fields, diffusely diminished
vesicular sounds, and mild digital clubbi ng. Th e
chest roentgenogram (Fig 1 ) showed scattered
coa rse reticular densities and subca rdi ac air .
Physiologic studies revea led a forced vital capacity of 3 05 liters {predicted value, 3.54 liters), a
one-second forced expiratory volume of 1 .68 liters/sec (predicted value , 2.44 liters/sec), and a
maximum mid-expiratory fl ow of 0 .96 liters/sec
(predicted value, 2 .98 liters/sec). Sweat chloride
values exceeded 60mEq/liter on three occasions, thus confirming th e diagnosis of cystic fibrosis.

Comments: There is evidence to suggest that
differences in genetic factors or penetrance
may influence the course of cystic fibrosis. 2
Some patients may not develop the typical
wasted and chronically-ill appearance and because of this , cystic fibrosis may be easily overlooked in adolescents or young adults . Futhermore , over 20% of cystic fibrosis patients may
remain unrecognized when they reach the age
of seventeen. 2 Case 1 is an example of this.
Misdiagnosis resulted in inappropriate and expensive attempts to provide protection from presumed pulmonary allergens. Earlier institution of
correct treatment , consisting of aggressive
chest physiotherapy and prompt attention to
specific airway bacterial pathogens , may have
improved her long-term prognosis . Because
80 /
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CASE 2 A 58-year-old fema le nurse complained
of progressive wheezing and dyspnea in December, 1 978 . She den ied smoking cigarettes, previous atopy, allerg ic rhiniti s, or asthma and had
experienced excellent hea lth until June, 1978,
when she developed episodic "tightness " in her
chest. This worsened in November, 1978 . causing her to seek medica l attention . Asth ma was
diagnosed and she was given a bronchod ilator
wh ich temporaril y relieved her symptoms In December she was hospitalized with severe wheezing and fever. Her past history revealed that she
had converted to a positive tuberculin test in
1 9 77 . She had refused to take prophylactic
ison iazid. A physical examination revealed an
elevated temperature (1 02 F), tachypnea. use of
accessory muscles of inspiration, and expiratory
prolongation of her breath sounds; bilateral diffu se expiratory wheezing was present. The total
leukocyte count was 16,1 00 cells/ cu mm with
78% mature neutrophils, 7% band forms , 6%
lymphocytes, 3% monocytes, and 6% eosinoph ils. The absolute eosinophi l count was 5056
ce lls/ cu mm. A chest roentgenogram (Fig 2) revealed a " ground glass" infiltrate in the left upper
lobe. Serologic tests fo r antibody titers to Mycoplasma pneumoniae, 0 fever, psittacosis, and a
variety of vira l agents known to infect the respiratory tract were low. Mycobacterium tuberculosis
was not present on sputum smears or cultures .
Arterial P0 2 was 54 torr , PC0 2 32 torr, pH 7.47
units. After five days of intravenous aminophylli ne
her wheezing cleared. Physiologic stud ies revealed a forced vital capacity of 2. 1 7 liters (pre-

Fig 2-Posteroanteri or chest roentgenogram of case 2
showing ill-defined "ground-glass" infiltrate (arrow) in left
upper lung fie ld.

nonspecific inflammatory changes and fibrosis.
Th e acute illness apparently resolved . During his
convalescence, physiologic studi es revealed
moderately severe obstruction. He was told th at
he had COPD related to his long-term smoking
habi t. However, he had smoked cigarettes only
occasionally and had been able to play tennis
and ski prior to his illness in February. Since then
he was dyspneic on exertion and unable to perform sports activiti es. In October, 1976 , he
sought anoth er opinion. A ph ysical examination
revealed a few scattered posterior wheezes and
moist ra les with a well-healed righ t thoracotomy
scar. Chest roentgenogram showed postsurgical
blunting of the right costophrenic angle but was
otherwise normal. Th e ph ysiologic studies (Table
I) conti nued to show moderately severe obstruction , obstructi ve air trapping, and severe reduction in diffusing capacity. Histopatholog ic section s of his previous biopsy were obtained and a
Van Giesson stain was performed (Fig 3). This revealed numerous remnants of bronchial wall elastin , unrecog nized on earlier hematoxylin and eosin staining, whi ch indicated severe bronchiolitis
obliterans.

dieted value, 2. 43 liters) , and one-second forced
expiratory volume of 1 .55 liters/ sec (predicted
value 1 .7 8 liters/sec). Th e left upper lobe had
cleared completely on roentgenogram but was
replaced by a similar infiltrate in th e left mid-lung
field . Because of these migratory infiltrates associated with eosinophilia , Loffler syndrome was
suspected . Twenty days after admission her
chest roentgenogram was normal. Physiologic
studies revealed a forced vital capacity of 2.27
liters, a one-second forced expiratory volume of
1.78 liters/sec; arterial P0 2 was 78 torr, PC0 2
36 torr , pH 7 .41 units.

Comments: Loffler pneumonia is the mildest
disorder in a group frequently described as
"pulmonary infiltrates with eosinophilia " or
" PIE syndromes ." The spectrum of PIE syndro mes also includes more debilitating disorders such as chronic eosinophilic pneumonia
(CE P) or potentially fatal disorders such as polyarteritis nodosa .3 Although the etiology and
pathogenesis of Loffler pneumonia are unkn own , recent detailed pathologic descriptions
of a single case have shown striking similarities
to CEP .4 Therefore , distinction between the two
may have to be made on clinical grounds .
Loffler syndrome is a self-limited form producing mild illness , whereas CEP is prolonged and
may result in severe restrictive impairment, occasional obstructive impairment and large ventilation-perfusion imbalances.3 CEP will resolve
rapidly with corticosteroid therapy, but relapses
are common . Loffler pneumonia rarely requires
corticosteroid therapy . The PIE syndromes may
be associated with obstruction , wheezing , and
peripheral eosinophilia ,3 thereby simulating
asthma as occurred in case 2 .
CASE 3. In February 1975, on th e eve of a skiing
trip , a 59-year-old male sorting machine mechanic developed chills and fever. These were
followed by malaise and dyspnea. Seven days
later a dry cough developed . Two weeks following th e onset of the illness, he was hospitalized
because of persistent symptoms and an abnormal chest roentgenogram showing coarse, bibasilar linear infiltrates. After an unrevealing, noninvasive work-up , he underwent a right lower lobe
open biopsy , which was interpreted as showing

Comments: Bronchiolitis with bronchiolitis obliterans is a well-recognized sequela of acute viral
infections in infants and children . Among children less than 2 years old, respiratory syncytial
virus accounts for most cases . 5 Because of their
severe and potentially fatal obstructive complications , adenovirus types 3, 7 and 21 are another important, although much less frequent ,
cause of bronchiolitis in this age group. 5 On the
other hand, acute viral bronchiolitis is rarely
diagnosed in adults . The occasionally recognized case of bronchiolitis obliterans can usually
be attributed to inhalation of a toxic substance,
with resultant chemical injury, or to a syndrome
of rapidly progressive airway obstruction which
is sometimes seen in rheumatoid arthritis .6 However , as a diagnosis by exclusion, viral bronchiolitis obliterans seemed likely in case 3. The
patient denied toxic inhalation and had no
chemical or serological evidence of rheumatoid
arthritis . His prodromal symptoms were suggestive of a viral infection. His subsequent clinical
course further supported this . Although the
pathogenesis and pathologic lesion in his illness

TABLE 1
Physiologic Studies in a 59-Year-Old Male with Bronchiolitis Obliterans
Vital capacity, liters
FEV 1 , liters/sec
Total lung capacity, liters
Residual volume, liters
Diffusing capacity, ml / min / torr

P RE-DRUG

P OST-BRONCHODILATOR

P REDICTED

2. 50
1.53
5.2 8
2.79
15.8

2. 58
1 .53

4 .64
3. 29
7.03
2 .39
27.7
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Fig 3 -Histopathologic section of lung biopsy from case 3 showing remnants of bronchiolar wall elastin enmeshed in fibrous
tissue. The findings are diagnostic of bronchiolitis obliterans (Van Giessen stain x 100).

were quite different from those of COPD related
to chronic cigarette smoking , his long-term
prognosis and hope for benefit from pharmacologic therapy are uncertain because the natural
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loops. The dotted line is a superimposed curve from the
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history of bronchiolitis obliterans in adults is not
well known .
CASE 4 . A 12-year-old white male was treated for
asthma for six years because of wheezing and
dyspnea. On a routine visit , inspiratory stridor
was detected. Spirometry showed mild obstruction (one-second forced expiratory volume 70%
of predicted). Because of his stridor, a flow-volume curve was performed to screen for upper airway obstruction. Both the inspiratory and expiratory limbs of this curve were flattened
indicating nonvariable upper airway obstruction
(Fig 4). A contrast tracheogram revealed an area
of extreme tracheal narrowing extending from the
level of the thyroid cartilage to the carina (Fig 5)
An anomalous right upper lobe bronchus communicated with the trachea at the level of the thoracic outlet The finding of anomalous bronchial
drainage in conjunction with the tracheal stenosis
suggested that all findings were of congenital origin . .

Comments.· Tracheal stenosis is usually associated with postinflammatory scarring because of
pressure necrosis from indwelling endotracheal
or tracheostomy tubes. Its occurrence as a congenital abnormality in a youth long suspected
of havin g all ergi c asthma underscores the
importance of correctly timing abnormal breath
sou nds . Earli er failure to recognize an in-

spiratory component to this patient's ''wheezing" misled the clinicians caring for him. Prolonged, and perhaps unnecessary, bronochodilator therapy exposed the patient to expensive
and potentially toxic medications. The extent of
the abnormality precluded surgical correction.
However, after a correct diagnosis was made,
close attention to clearance of secretions and
recognition of a permanently limited exertional
tolerance helped the patient and his family to
cope with his condition .
CASE 5. A 36-year-old black male complained of
exertional dyspnea and massive swelling bf his
lower extremities in March, 1979. These symptoms were oi 12 months' duration and had progressed to the extent that he was short of breath
with minimal exercise such as dressing himself.
He noted frequent nocturia, intermittent orthopnea, and was hypersomnolent during the day. A
physical examination revealed massive obesity.
His height was 5 feet, 9 inches; his weight was
344 pounds. The thyroid gland was not palpable
and there were no changes ih hair texture or
quality of his voice. The chest was clear to auscultatiofil. Head sounds were faint with an S4 gallop. Pitting dependent edema to the level of the
umbilicus was present. Serum urea nitrogen, glucose, and electrolytes were normal as were the
urinalysis and total leukocyte count. Hemoglobin
was 1 9.7 gm%. An electrocardiogram showed
right axis deviation . Serum free thyroxine was
normal. A chest roentgenogram revealed cardiomegaly. The arterial P0 2 was 38 torr, PC0 2
was 56 torr, pH 7.36 units. Supplemental oxygen, digoxin, and furosemide were administered.
Physiologic studies (Table 2) showed mild restriction and no evidence of obstruction . During
sleep, the patient was observed io snore loudly
between apheic spells. This phenomenon was
documented by simultaneous sleep recordings of
el!3ctroencephologram ' electrocardiogram ' intraesophageal pressure (an estimate of intrapleural
pressure), and air flow at the mouth (Fig 6). While
in stage II non-rapid-eye movement sleep, he
demonstrated numerous prolonged apneic spells
during which he continued to have phasic inspiratory efforts, as manifested by persistent
swings in intrapleural (intraesophageal) pressure.
This confirmed the diagnosis of obstructive sleep
apnea.

Comments: Disordered control of breathing during sleep may produce prolonged nocturnal

hypoxemia and hypercapnia. These; in turn,
may cause nocturnal pulmonary hypertension
and gradual '' resetting ' ' of the central chem~
oreceptor response to C0 2 . Eventually, chronic
hypercapnia and cor pulmonale will occur. Although the precise sequence leading to chronic
cor pulmonale and hypercapnia are unknown,
at least three distinct pathophysiologic mechanisms may produce a ventilatory sleep disorder.
The first , and most common, occurs in patients
with COPD in whom exaggerated deterioration
in arterial oxygenation and C0 2 retention may
accompany the normal decrease in alveolar
ventilation during sleep. The second occurs in
patients with congenital or acquired defects in
brain stem chemoreceptor or respiratory integrative functions. They develop apneic spells
during sleep because respiratory drive from the
cortex normally ceases, but the brain stem control mechanisms are unable to maintain normal
ventilation .8 The third results from intermittent
upper airway obstruction, which leads to alveolar hypoventilation interrupted by loud snoring
spells. Patients with anatomic defects of the upper airway, such as mandibular malformations
or tonsinar hypertrophy, are predisposed to this
condition .8 However, the majority of patients
with obstructive sleep apnea have no recognizable anatomic defect, and the precise mechanism for their intermittent upper airway obstruction remains unknown .8 They tend to be obese.
Because their sleep pattern is interrupted by frequent hypoxic spells with arousal, they tend to
be hypersomnolent during the day. By the time
they seek medical attention , they ar~ :usually experiencing cardiorespiratory failure. It,. is apparent that these patients have the cardinal features of what was formerly called the
" Pickwickian syndrome." Case 5 is an example of this phenomenon . Often these patients
are diagnosed as having COPD because they
have chronic C0 2 retention and are assumed to
have chronic diffuse airway obstruction. Misdiagnosis of such patients may result in grave
therapeutic errors. The prognosis for untreated
obstructive sleep apnea is poor, but the condi-

TABLE 2
Physiologic Studies in a 36-Year-Old Male with Obstructive Sleep Apnea
OBSERVED
PREDICtED
Vital capacity, liters
3 .60
5.07
FEV;, liters/ sec
3.00
3 .94
' 78
FEV,/vital capacity,%
83
Maximum mid-flow, L/ sec
3 .26
4 .14

%PREDICTED
71
76
79
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Fig 5-Tracheogram from case 4 showing long segment of
narrowed trachea well outlined by contrast material. Right
upper lobe bronchus branches from trachea above the carina indicating congenital anomalous bronchial tree with tracheal stenosis.

tion may be alleviated by the performance of a
tracheostomy to allow for a patent airway during
sleep.
In addition to the examples discussed in
this report , there are other lung disorders which
may cause obstructive airways disease or C0 2
retention (Table 3), either as an occasional
complication or as a dominating feature.
Kyphoscoliosis can produce chronic C0 2 retention and cor pulmonale. However, the mechanisms initiating this are obscure because restriction, rather than obstruction , is the
predominant mechanical abnormality. 9 Advanced tuberculosis may also cause chronic
C0 2 retention. Again, the precise mechanism is
ill-defined although inflammatory bronchial stricture with subsequent obstruction may play a
role. 9 Because both of these diseases are easily
recognized, confusion with asthma or COPD
should rarely occur .
'' Occupational asthma, '' on the other
hand , may be difficult to distinguish from the
more common allergic asthma of atopic individuals. In the former , patients experience reversible airways obstruction after exposure to specific organic volatile compounds or fibers.

Fig 6-Sleep recording from case 5 showing continued inspi ratory attempts (phasic esophageal pressure) during apneic spell
as indicated by absence of mouth or nasal air flow. Unlabled channels are electroencephalograms. " EOG" is electrooculograni showing absence of rapid-eye-movements during thi s apneic spell.
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Although reaginic antibody may be a factor ,
predisposition to the development of occupational asthma may be unrelated to the previous
atopic status of affected individuals. 10 A number
of compounds have been implicated, common
examples of which are toluene diisocyanate,
used in the manufacture of polyurethanes, and
cotton or hemp dusts, encountered in the milling and carding processes of textile industries. 10
Noninfectious, granulomatous inflammatory diseases of the lung may produce chronic
airways obstruction and thereby create diagnostic confusion , especially because these
diseases more commonly produce restrictive
defects. Histologically, granulomatous bronchiolitis is almost invariably seen in allergic alveolitis and sarcoidosis. It is not surprising,
therefore, that as many as 25% of patients with
these disorders have reduced one-second
forced expiratory volumes when expressed as a
ratio of the forced vital capacity. 1 1 · 1 2 On occasion, obstruction is the dominant mechanical
deficit in these patients and can occur with
equal frequency in those with or without a
smoking history.
Lymphangioleiomyomatosis is an exceedingly rare disease of women in childbearing years in which hyperplastic nodules of
atypical smooth muscle cause obstruction of
p ulmonary lymphatics, venules, and bronchioles. These, in turn , produce episodic chylothorax, hemoptysis, and progressive obstructive airways disease. 13 In addition, chest
roentgenograms in this condition show reticular
markings associated with supernormal radiographic lung volumes. Although this constellation of clinical findings is distinctive, the
disease is so rare that the diagnosis is often not
made without open lung biopsy. Unfortunately,
the prognosis for women with lung involvement
is poor with most patients dying within ten years
of the onset of symptoms. 13
Respiratory compensation for severe
metabolic alkalosis may result in ''chemically
justifiable" C0 2 retention in order to minimize
elevation in pH. This well-known phenomenon
is overlooked with surprising frequency by noninternists who may be less familiar with interpreting arterial blood gas data and may automatically attribute C02 retention to ventilatory
fai lure. Carried to its full extent , such an error in
logic may produce a corresponding error in
treatment. Fortunately, most clinicians recog-

TABLE 3
Conditions Which Mimic Asthma or COPD
1.
2.
3.
4.

5.
6.
7.
8.
9.
1 0.
11.
12.

Upper airway obstruction•
Sleep apnea syndromes •
Cystic fibrosis•
Kyphoscoliosis
Advanced tuberculosis
Pulmonary infiltrates and eosinophilia (PIE)*
Bronchiolitis obliterans (viral,
toxic inhalation, rheumatoid)•
Industrial asthma
Sarcoidosis
Allergic alveolitis
Lymphangioleiomyomatosis
Severe metabolic alkalosis

• Discussed in comments of case reports

nize the phenomenon before instituting therapy
for acute respiratory failure .
Table 3 represents only a partial list of diseases which may mimic asthma or COPD . As illustrated by th e case reports, correct interpretation of wheezing , obstruction, and C0 2
retention depends not only on a knowledge of
their differential diagnosis but also on obtaining
an accurate history and physical examination.
Special studies, such as the flow-volume curve
illustrated in case 4, are merely confirmatory
data. These special studies are appropriate only
when clini cal and screening laboratory data
suggest a specific diagnosis. Therefore, the
availability of such studies in many medical centers has not diminished the important role of
basic bedside clinical skills in the diagnosis of
obstructive lung disorders.
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Chronic Obstructive Pulmonary Disease:
Outpatient Management
JAMES P. BAKER , M.D .
Professor and Chairman, Department of Medicine, Eastern Virginia School of Medicine , and Director,
Pulmonary Care Unit, Norfolk General Hospital, Norfolk, Virginia

Chronic obstructive pulmonary disease
has become one of the more common problems which face physicians both in inpatient
and outpatient settings. The incidence of the
disease and increase in mortality have been
documented in a number of studies as have
other lung diseases, indicating a general rise in
pulmonary disorders over the past several decades. 1- 3 Two types of disease are classified under the heading of chronic pulmonary disease:
chronic bronchitis and pulmonary emphysema .
Chronic bronchitis is defined as a clinical syndrome of cough and sputum production for
three consecutive months over two consecutive
years, and pulmonary emphysema is defined as
the histological expansion and destruction of
the terminal respiratory units, with loss of structural elements. The etiologies associated with
these diseases probably are multiple and are
beyon'd the scope of this discussion; however,
two of the causal factors are a hereditary predisposition such as is seen in alpha1-antitrypsin
deficiency and the continued irritation of respiratory tissues by various air pollutants including tqbacco smoke .4
The following discussion of a therapeutic
program for those who suffer from chronic obstructive pulmonary disease is directed toward
the possibility of maintaining a patient in an outpatient status because of the need to minimize
health care costs . 1 - 5
The pathogenetic mechanisms of respiraCorrespondence and reprint requests to Dr. James P.
Baker, Director, Pulmonary Care Unit, Norfolk General Hospital, 600 Gresham Drive, Norfolk, VA 23507

tory distress associated with chronic obstructive
pulmonary disease share several common denominators (Fig 1 ). The primary problem is airways or bronchial obstruction, thus the physician should attempt to relieve this condition to
prevent the cascade of effects that may occur
later in the course of the illness. Obviously,
bronc·hial irritation and infection lead to bronchial edema , spasm and hypersecretion with resulting bronchial obstruction . This can cause a
number of difficulties the more important of
which are problems of pulmonary infection and
atelectasis, ventilation-perfusion disturbances
with consequent hypoxemia, hypercapnea, and
ultimately cardiovascular death, primarily from
arrhythmias. The series of steps that can be
taken to avoid the natural progression of these
problems to mortality are outlined in the Table.
A major concern for patients with chronic
pulmonary illness is the necessity of being reassured that their physician is taking an active interest in the treatment and follow-up care of
their case . While there is no total cure for
people with chronic pulmonary disease, a reasonable lifestyle can be maintained in most
cases where the physician is ready to present
an optimistic outlook and offer encouragement
in those aspects of treatment that require the
patient's cooperation. Such guidance is an important therapeutic factor in combating this illness and provides significant satisfaction to the
physician for the time and interest expended .
Patients with chronic pulmonary disease
must avoid respiratory irritants; first of all they
must stop smoking . There is ample evidence
that while people who have pulmonary impairMCV QUARTERLY 15(3):87-90, 1979

I 87

>

BRCNCHIAL

BROOCHIAL
INFECTIOO

I~IOO oC(;

~CHIALID~

r= .,.,.,r~,.,,i
i

SPASM, HYPERSEX:REI'IOO

uneven

vl~ti>atirn <-

J

~

~

I.
'V'

Decreased
Ventr~cufar

Functioo

~

Distrudtion of Alveolar walls

Change in
Corrpliance

.\ I
ij.,

uneven

Per.

.

\

.____.-

~

"'>

Fati'\

fusion

~ <.

l

Pulrronary. c(
Hypertension

~

:c~7e

respo.""lSa

uf

..i

Increased

Increased work
of breathing

ii

~

Narrowing and loss
of Capillary bed

~ Polycythemia
-

l

~
~ Pneuroru.a
Loss of Elastic Tissue and
~
-l1

rXFMIA~

Increased
Cardiac
output

___________--:REI'AINED INFECl'ED SEX:RETIGIS

HYPOVENrIIATIGI

Increased

"'"'°"'"'~
<;

/

.

Hypercapru.fl

Cardiac
Arryt.."1mia ·

..i,

Death

Fig 1-Pathogenesis of respiratory failure in chronic obstructive pulmonary disease. Remediable aspects in capitals.

ment and stop smoking continue to have an
FEV1 that is less than predicted for their size
and age, the rate of decline in lung function is
significantly slowed .7 This is one of the more difficult aspects of treatment to accept and many
patients deny that not smoking is of value. It is
important that the physician continue to encourage these people not to smoke, and to maintain
follow-up of those who will not stop . In addition
to cigarette smoking, patients should avoid
other known environmental respiratory irritants
as well as any inhaled allergens if they are
known and can be documented. One of the
most important aspects of a therapeutic program is to provide these patients with a home
that is as free from irritants and allergens as
possible: pets should be kept outdoors; dust
generators should be removed from the bedroom, as this is where the patient spends the
most time; nonallergenic pillows and bedclothes
should be purchased; and all animal and cotton
products should be removed from the bedroom
if possible and only synthetic, nonallergenic fibers used in rugs, upholstered furniture, draperies, and other items. Consideration should be
given to purchasing an air filter for the bedroom
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as well as one for the entire home if simpler
measures are ineffective.
The atmospheric environment should be
controlled at between 40% and 60% relative
humidity. In addition to this, patients with
chronic pulmonary disease should drink large
quantities of liquid each day to assist in
liquefying the great amount of thickened secretions that their lungs produce; a good rule of
thumb is 1 2 to 1 4 glasses of water daily or an
adequate amount of water to dilute urine to the
point that it looks like water. A vaporizer at
times of increasing respiratory secretions such
as with an upper respiratory infection may also
be useful.
Bronchial drainage measures should be
practiced using a simple four-position technique; three of these positions are illustrated in
Figure 2. 5 The patient lies with hips elevated
above the shoulders in each position (in addition
to face-up) for 5 minutes twice daily. If.a family
member can be taught chest percussion and/
or vibration, this can assist in the removal of the
increased tenacious secretions. The next procedure is to teach the patient pursed-lip breathing
which requires that the patient exhale through

pursed lips as though he or she were whistling.
This will slow respiratory rate and may maintain
airways in an open position for a longer time
during exhalation , thus decreasing air-trapping
and improving ventilation-perfusion relationships.
Since many severe pulmonary difficulties
begin with upper respiratory infections, these
chronically-ill patients should be instructed to
keep antibiotics such as tetracycline or ampicillin in their home, and to start on these drugs as
they develop either an upper respiratory infection or a change in sputum color or quantity
which suggests an increase in infection . The patient 's physician should then be called and, depending upon the degree of difficulty the patient
is having, the physician should have a Gram
stain and/ or culture done of the patient's sputum .3
The regular use of bronchodilators is a
cornerstone of therapy for chronic pulmonary
disease. 3 · 5 6 Patients must be encouraged to
take their' drugs daily even though their condition is quiescent. The newer anhydrous aminophyllin preparations are generally the best available. The addition of sympathomimetics such
as terbutaline or metaproterenol is appropriate if
further bronchodilation is needed. Inhaled
bronchodilators are also helpful, but they should
be used infrequently, as these drugs are easily
overused. Patients taking inhaled drugs must be
given careful instructions with a demonstration
of their proper use. The nebulizer is positioned
just distal to the open mouth and a deep breath,
followed by complete exhalation, is accomplished to time appropriately the introduction of
the medication at the beginning of the next inspiration; at the onset of this inspiration the
medication is nebulized via the open mouth.
The patient holds his or her breath for as long
as possible following a maximal inspiration and
slowly exhales through pursed lips. This process should be repeated two to three times with
two to three puffs of bronchodilator each time.
Patients should be taught to monitor their pulse
rate and rhythm when taking this type of medication and to discontinue its use if they develop
any arrhythmia or tachycardia.
Another classification of drugs considered
for therapeutic use is the adrenal corticosteroids
which may be given either in inhaled or oral
forms with the inhaled form producing fewer
side affects. The introduction of steroid therapy

TABLE
Chronic Obstructive Pulmonary Disease: Outpatient
Management

1.
2.
3.
4.
5.
6.
7.
8.
9.
1 0.
11 .
12.

Physician interest and frequent follow-up
Avoidance of respiratory irritants
Maintenance of adequate humidity and hydration
Practice of bronchial drainage measures
Control of infection
Regular use of bronchodilators
Use of oxygen
Use of steroids
Control of heart failure
Other drugs
Active exercise reconditioning
Patient and family education

should be based upon indication of failure of the
above-mentioned bronchodilators and antibiotic
therapy, or evidence of a clear-cut allergic disorder shown by either nasal or sputum eosinophilia or severe irritation by known allergens.
The goal of steroid therapy should be to use the
drugs in their inhaled form and if that is impossible to use minimal amounts of the oral drugs
on alternate days to decrease side effects. 8
Another drug available for use is cromolyn
sodium; patients with definite allergic abnormalities or evidence of allergic-oriented disease are
more likely to respond to this drug. There is no
place for the use of either sedatives or tranquilizers in the treatment of chronic respiratory dis-

Fig 2-Basic positions for bronchial drainage.
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ease. These patients are generally anxious, agitated, and frustrated because of their illness
and / or the hypoxemia and / or hypercapnia
which are associated with the disease. They are
quite sensitive to most tranquilizers, particularly
the benzodiazepams (Valium , Librium , among
others), and these drugs should be avoided . A
possible drug for use is hydroxozine (Atarax ,
Vistaril) which at least in parenteral form does
have some bronchodilator effect and may be
taken as a last resort in small doses (1 0 mg ,
t.i.d.) after all other possibilities have been exhausted.
Many patients will have observable evidence of right heart failure or cor pulmonale
which should respond to the therapeutic regimen suggested above; if they do not, first, diuretics should be tried , and if they are unsucessful , digitalis may be used. Digitalis generally does not improve right heart failure as much
as left heart failure, although it does have some
effect. It is important to avoid drugs which block
the effectiveness of beta adrenergic stimulation,
particularly propranolol which is a beta 1- and
2-blocker , as they will make the bronchodilators
less effective. An effective beta 1-blocker drug
may be available in the not-too-distant future
which will permit bronchial dilatation while controlling cardiac arrhythmias without producing
the kind of problem one regularly sees with beta
1- and 2-blockade.
Active exercise reconditioning is of great
importance for patients with chronic pulmonary
disease. 1 - 3 · 5 · 5 They should begin with a regular
walking program in which goals are set, such as
walking a number of blocks (or other measured
distance) daily in a specified period of time , with
a planned increase in the rate of walking or a
decrease in the amount of time it takes to cover
a certain distance. In addition to this, having an
exercise bicycle for indoor use during inclement
weather is of extreme importance. Exercise with
nasal oxygen may increase the exercise tolerance of the patient and permit more rapid progress; its use in the outpatient setting has been
demonstrated to be of significant value in reducing pulmonary hypertension and improving the
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psychological status of chronically hypoxemic
patients.9
In conclusion, an educational program in
which the family as well as the patient is provided with information concerning the etiology
of the disease is very important; a similar one
which explains the pathogenetic mechanisms
involved in the illness, what the course and
prognosis are likely to be, as well as the rationale for all therapeutic measures introduced, is
also very helpful. This type of approach will assist most patients to improve and function more
effectively.
Figure 2 is reprinted with permission from Dr. Irwin
Kass.
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Recent Advances in the Management of
Chronic Airway Obstruction
JAMES A. L. MATHERS, JR., M.D.
Assistant Professor of Medicine, and Medical Director, Pulmonary Function Laboratory, Medical
College of Virginia, Health Sciences Division of VirQinia Commonwealth University, Richmond, Virginia

Recent advances in our understanding of
the natural history of chronic airway obstruction
have identified aspects of this process that may
enhance the morbidity and mortality of patients
with a progressive increase in airway resistance.
These advances have helped us to be more
specific in the investigation and quantitation of
the disease in the pulmonary function laboratory
and to be more precise in our therapeutic management. Experience has taught us that the
most useful measurement with which to characterize the degree of disease and its rate of progression is the forced expired volume in one
secorid (FEV1) . The comprehensive studies of
Dr. Charles Fletcher in London have demonstrated that the single most important therapeutic factor is avoidance of all airway irritants.1
The application of aggressive bronchial hygiene
in patients with obstructive airways disease may
produce an initial improvement in the FEV 1 but
will not in itself alter the rate of decline in pulmonary function . As the degree of airway obstruction increases, a number of interrelated physiologic abnormalities develop including
hypoxemia, hypercarbia, polycythemia, cor pulmonale, and eventually, acute or chronic respiratory failure. These abnormalities account for
most of the morbidity in this condition and the
majority of patients who develop them have a
high degree of airway obstruction . It is not unusual, however, to see patients with a moderate
degree of airway obstruction who also manifest
Correspondence and reprint requests to Dr. James
A. L. Mathers, Jr., Box 50, Medical College of Virginia,
Richmond, VA 23298.

these problems. The purpose of this paper is:

(1 ) to review the relationship between a progressive increase in airway obstruction and the associated physiologic abnormalities, and (2) to
discuss the therapeutic interventions that show
promise of reducing the morbidity from these
accelerated physiologic abnormalities .

Hypercarbia and Airway Obstruction
In order to identify those patients whose
clinical condition is significantly worse than anticipated from their level of airway disease, we
need a readily applicable laboratory marker
such as the elevated arterial carbon dioxide tension (PaC0 2 ) . Several years ago, the relationship between airway obstruction characterized
by the FEV 1 and the PaC0 2 was investigated. 2 It
was noted that when the FEV1 was 1500 cc or
greater, the PaC0 2 was normal (PaC0 2 < 44
mm Hg). When the FEV 1 fell below one liter, the
patient was as likely to have an elevated PaC02
as he was to have a normal PaC0 2 , and when
the FEV1 was 500 cc or less, the PaC02 was almost always in excess of 44 mm Hg. Hypercarbia has been identified as an adaptive response in those patients who must balance the
increased work of breathing against adequate
carbon dioxide clearance and, indeed, this may
be true in patients with severe airways disease.
Such a state, however, has two major disadvantages; increased arterial hypoxemia ~md promotion of metabolic alkalosis, which contribute to a
cycle of events that leads to premature metabolic deterioration . We have identified patients
with moderate obstructive airway disease
whose hypercarbia, previously attributed to the
MCV QUARTERL y 15(3):91-96, 1979
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airway disease, was in fact, related to conditions amenable to medical management. Furthermore, there are patients who have severe
obstructive airway disease whose hypercarbia
is made worse by these same factors . These
conditions include respiratory disturbances during sleep, metabolic alkalosis , and respiratory
muscle weakness .

Respiratory Alterations During Sleep
Recent studies using an ear oximeter have
clearly demonstrated that gas exchange is not
stable from moment to moment during the day
and that a single arterial puncture is not satisfactory to describe an individual's blood gas
composition, particularly during exercise and
during sleep. Healthy adults develop periodic
breathing during light sleep with an overall reduction in minute ventilation of one to two liters.
Rapid eye movement (REM) sleep may include
apneas of 1 5 to 20 seconds in normal individuals. Accompanying these episodes, there is an
elevation in PaC0 2 of 4 to 8 mm Hg and a reduction in arterial oxygen tension (Pa0 2 ) of 3 to
1 0 mm Hg. In patients with chronic obstructive
airway disease, similar fluctuations are found
but with more profound blood gas disturbances
that are not directly related to the degree of respiratory impairment when awake. There are
three major abnormalities of respiration that
may occur during sleep. These are (1) hypoventilation, (2) central apnea, and (3) obstructive
apnea. Patients with chronic airway obstruction
may suffer from any of these entities; however,
the two former problems are far more common
than obstructive apnea . Episodes of hypoventilation causing hypoxemia and hypercapnia are
usually brief but have been reported to last up to
one hour. Alterations in chest wall mechanics
and airway tone during REM sleep may increase these episodes. Normal, brief central apneas may be prolonged by alterations in the
ventilatory control of the central nervous system. An increase in hypoxic drive produces a
Cheyne-Stokes breathing pattern. Depression
of either the hypoxic or hypercapnic drives may
prolong the apneic spells.
Spells of nocturnal hypoxemia have been
demonstrated to cause episodic pulmonary arterial hypertension, fluid retention, and polycythemia. It has been suggested that recurrent
arterial hypoxemia during sleep produces a sustained elevation of the pulmonary arterial pres-
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sure and cor pulmonale. A major factor contributing to the prolongation of these episodes of
hypoxemia is the depression of the central ventilatory response to hypercarbia. As the PaC0 2
rises, respiratory acidosis develops and repeated and prolonged bouts of acidosis stimulate a compensatory metabolic alkalosis . This
renal adjustment to hypercarbia is a "compromised adaptation' ' in which the respiratory
acidosis is buffered by an increase in serum
and extracellular bicarbonate, but this elevated
bicarbonate in turn promotes a readjustment of
the respiratory control mechanism favoring perpetuation of the hypercapnic state. This effect
of an elevated serum bicarbonate on the respiratory control mechanism has been demonstrated in patients with and without respiratory
compromise .3 Nocturnal hypercapnia in a patient with modest airway disease may initiate
progressive elevation of the serum bicarbonate
which in turn will alter the respiratory control of
the central nervous system and lead to a sustained elevation of arterial carbon dioxide tension during the waking hours . Furthermore,
such an alteration prolongs the nocturnal apneic spells increasing both the arterial hypoxemia and hypercapnia.
This unfortunate situation may be magnified by the administration of chloride-depleting
diuretics that are often given for fluid retention.
Clinical experience has impressed upon us the
fact that patients with moderate-to-profound arterial hypoxemia respond poorly to large doses
of diuretics until their arterial oxygenation has
been improved, which alone is often sufficient
to promote a diuresis. The interrelationships
among these abnormalities that occur during
sleep are shown in Figure 1 . There are several
points in this cycle in which the physician may
intervene. The most quickly reversible problem
is diuretic-induced alkalosis. When we encounter a patient with a marked elevation in serum
bicarbonate who has been on chloride-depleting diuretics, we discontinue the diuretic therapy and treat the patient with either a carbonic
anhydrase inhibitor such as acetazolamide or
by the administration of ammonium chloride.
The effect of reducing the serum bicarbonate in
a group of patients with severe obstructive lung
disease whose metabolic alkalosis was in excess of that appropriate for the arterial carbon
dioxide tension has been reported. 4 In these patients diuretic therapy was discontinued and

METABOLIC ALKALOSIS

CHLORIDE DEPLETING
DIURETICS

ACIDOSIS

DEPRESSED CENTRAL RESPIRATORY DRIVE

~

tP.A.P.
FLUID RETENTION

I

HYPOVENTILATION
HYPERCARBIA

I SLEEP I
Fig 1-Abnormalities of gas exchange during sleep.

acetazolamide 500 to 750 mg/day in divided
doses or ammonium chloride 3 to 6 gm/day in
divided doses was administered until the serum
bicarbonate, PaC0 2 and arterial pH stabilized .
The effect of this therapy on the arterial blood
gas composition of 11 patients is summarized
in Table 1.
Following the line of reasoning that a central control mechanism may be abnormal in patients with prolonged nocturnal hypoventilation,
a number of physicians in this field have been
investigating the use of medroxyprogesterone.
This agent has been used in an attempt to increase minute ventilation in a variety of pulmonary problems with variable success . The most
striking benefit seems to occur in those patients
whose apneic spells are limited to hypoventilati on on a central basis. Impressive improvement

in arterial blood gas composition has been reported in patients with obesity hypoventilation 5
and chronic airway obstruction. 6 While correction of metabolic alkalosis and the use of progesterone can be of significant benefit to these
patients, the administration of low-flow oxygen
during sleep may be a necessary addition, especially for patients whose Pa0 2 when awake is
less than 60 mm Hg. The effect of nocturnal ox-

TABLE 1
Blood Gas Values Before and After Correction of
Metabolic Alkalosis
AFTER
BEFORE
CORRECTION
CORRECTION
HC0 3 mmol/L
PaC0 2 , torr
Pa0 2 , torr

36.9±1.7
60.8 ± 2.6
52.4 ± 3.1

28.1±1.0
47.6 ± 2.2
69.1±2.1
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TABLE 2
Hypoxemia During Sleep in 10 Patients with C.O.A.D. on Room Air and Supplemental 0 2
Sa0 2 Breathing Room Air
Sa0 2 on 2L. 0 2
Mean
S.D.

AWAKE

ASLEEP

CHANGE

AWAKE

ASLEEP

CHANGE

95
4

68
12

- 26
11

97
2

86
9

-11
8

ygen therapy has been described in a group of
patients with moderate airway obstruction
(Table 2) 7 The data here are in terms of arterial
oxygen saturation (Sa0 2 ) and not Pa0 2 . The
mean waking arterial oxygen saturation was
95% while the mean sleep saturation was 68%
(a value associated with pulmonary arterial hypertension and polycythemia). The administration of low-flow oxygen to this group of patients
significantly improved the oxygenation during
sleep.
Abnormalities of ventilation during sleep
remains a fertile field for investigation and the
application of therapeutic modalities. We at the
Medical College of Virginia are most interested
in the documentation of breathing disturbances
during sleep in patients believed to have accelerated physiologic deterioration. In conjunction
with the Department of Neurology, we have developed a Sleep Study Center in which the presence of episodes of hypoventilation, central apn ea or obstructive apnea may be readily
determined and correlated with the stage of

sleep. It is believed that after careful documentation of these abnormalities and the application
of appropriate therapy, we may significantly reduce the morbidity that develops in the group of
patients with moderate airway obstruction and
premature carbon dioxide retention .

Respiratory Muscle Weakness
A great deal has been learned about the
function of the respiratory muscles in recent
years. The ability of patients with obstructive airways disease to sustain ventilation and avoid
hypercapnic respiratory failure depends upon
the strength and endurance of the respiratory
muscles. The major causes of muscle failure in
obstructive airways disease are ( 1) hyperinflation of the lung, (2) increase in airway resistance increasing the work of breathing, and (3)
generalized muscle weakness. The development of respiratory muscle :failure may be divided into two phases; muscle hypertrophy and
muscle atrophy.
In the early stages of airway obstruction ,
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Fig 2-The development of muscle weakness.
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hyperinflation of the lung pushes down on the
diaphragm shortening its resting length; as the
muscle is progressively shortened, the ability to
develop contractile force is reduced. At the
same time, the increase in airway resistance
and the increase in required minute ventilation
increase the demands on this compromised
muscle. In this early stage, it appears that there
is hypertrophy of the diaphragmatic muscle. As
the disease progresses, some patients begin to
lose weight, most frequently because of inadequate diet, or an inability to eat a complete
meal because of dyspnea. These patients develop a negative nitrogen balance and their loss
in general muscle mass is shared by the diaphragm, to the point of producing hypercapnic
respiratory insufficiency. In the Pulmonary Function Laooratory we test inspiratory and expiratory muscle strength with a pressure manometer but the presence of this problem can
often be suspected during the physical examination by noting generalized muscle tone, evidence of recent weight loss and asynchronous
breathing. Asynchronous breathing develops
when the diaphragm becomes so weak that it
no longer acts as an inspiratory muscle with depression of the abdominal contents and protrusion of the abdomen during inspiration. Instead,
it becomes passive and is sucked up into the
chest when the accessory muscles of inspiration are called into play causing retraction
of the abdomen during inspiration . The events
leading to this condition are seen in Figure 2 .
There are a number of points of therapeutic intervention. The increased airway resistance
may be treated with bronchodilators and aggressive airway hygiene to mobilize secretions.
Hypoxemia may be reversed with supplemental
oxygen, and malnutrition may be treated by ensuring an adequate diet. Frequently, several
small feedings, high in protein content, are necessary in patients who become dyspneic during
eating. Two other forms of therapy are currently
under investigation and may add significantly to
our management of these patients. One is
breathing training and exercise programs; the
other is the use of intermittent mechanical sup. port. The former may be useful in those patients
whose condition is caused by purely mechanical factors while the latter is reserved for those
who have developed evidence of diaphragmatic
atrophy. When a patient with evidence of
marked muscle weakness is placed on either

TABLE 3
Investigation of .Hypercapnia
Pulmonary Function Tests
FEV 1 > 800 cc
iPaC0 2 with Hyperventilation
Metabolic Alkalosis
1) Review diuretic use
2) Seek history of sleep disturbance
3) Obtain sleep study
4) C0 2 response curve
Muscle Weakness
1) Obtain diet and weight history
2) Examine for :
a) Paradoxical abdominal motion
b) Deltoid wasting
c) Use of accessory muscles
3) Request static muscle pressures
4) lnspiratory /expiratory chest X-rays

positive pressure ventilation or in the tank respirator , there is a marked decrease in inspiratory muscle contractile effort and relief of
dyspnea. Many physicians now feel that periodic rest for this overworked muscle combined
with an adequate diet will improve the patient's
ability to sustain ventilation. Patients with this
problem are currently being managed at home
with Drinker-type tank respirators in which they
may sleep or spend several hours per day. The
initial result of this therapy has been a marked
reduction in the amount of hospitalization these
patients require.
In summary then, there are a number of
factors, previously often unnoticed, that complicate the clinical picture of chronic obstructive
airway disease. With the recent advances in our
knowledge and diagnostic techniques, we may
more precisely define patients whose deterioration is premature. Premature deterioration may
be suspected when the PaC0 2 is elevated in an
individual whose FEV, is in excess of 800 cc
and who is able to reduce the PaC0 2 with voluntary hyperventilation. The presence of sleep
abnormalities, metabolic alkalosis or muscle
weakness may then be confirmed by further investigation as outlined in Table 3. Appropriate
therapeutic intervention may produce significant
improvement in the patient's condition and reduce the frequency of hospitalization .

Table 1 is adapted by permission from the Canadian
Medical Association Journal(11 7:900-903, 19 77)
Table 2 is adapted by permission from Annals of Internal Medicine(86 725-730, 1977).
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Pre- and Postoperative Care of Pulmonary
Patients Undergoing Nonthoracic Surgery
R. PAUL FAIRMAN , M.D.
Pulmonary Division, Medical College of Virginia, Health Sciences Division of Virginia Commonwealth
University, Richmond, Virginia

Introduction
A variety of pulmonary complications occur in patients during and following nonthoracic
surgery. These may include hypoxemia, atelectasis, bronchitis, pneumonia, and respiratory
failure . The incidence of these complications is
high and remains a major cause of morbidity
and mortality in the postoperative state . Even
so, this morbidity may be underestimated since
hypoxemia, the most common pulmonary complication , exerts its influence throughout many
organ systems through inadequate tissue oxygenation.
Physiologic Alterations Following Surgery
Predictable alterations occur in the pulmonary system in all patients undergoing surgery
and general anesthesia regardless of age or underlying illness; the major impairment is a reduction in lung volume. 1 Total lung capacity and
all its subdivisions (vital capacity, residual volume, functional residual capacity, and other
factors) are decreased ; in addition, expiratory
flows (FEV,) are reduced to a similar degree.
These changes occur during the operative procedure, are maximal within the first 24 hours
and slowly resolve over five to ten days. The
magnitude of decline is related to the location of
the surgical procedure; operations on the upper
abdomen generally result in reductions of 50%
to 60% . Following lower abdominal procedures, lung volumes and flows decrease by
Correspondence and reprint requests to Dr. R. Paul
Fairman, Box 50 , Medical College of Virginia, Richmond ,
VA 23298

25%. There is no change in pulmonary function
following operations on the extremities or the
head and neck area.
With the change in volume, the lung becomes less distensible (reduced compliance},
airways close and alveoli collapse , especially in
dependent portions of the lung. Because of
these abnormalities, there are areas in the lung
in which ventilation is reduced but perfusion
continues , resulting in hypoxem ia. This decrease in arterial oxygen tension approximates
20 torr following upper abdominal surgery in
normal persons.
Postoperatively, the respiratory rate increases and tidal volume decreases, although
total minute ventilation is unchanged. Periodic
deep inspirati ons , such as with sighs and
yawns, are less frequent also . This unvarying
pattern of respiration leads to alveolar collapse
and a progressive decline in compliance and arterial oxygen tensions. These changes in respiratory pattern have been ascribed to postoperative pain and p oo r mo ti o n o f the
diaphragm. However, administration of narcotics to alleviate pain accentuates these changes
as patients are reluctant to cough or take periodic deep breaths. This leads to retention of secretions, eventual atelectasis, and occasionally,
pneumonia.
Because of tissue repair and healing, the
metabolic rate is increased following operative
procedures, resulting in an increase in respiratory demands approximating 1 5% to 25%. In
addition , the work of breathing is increased because of the fall in lung compliance . Thus, in
the postoperative state, the respiratory system
MCV QUARTERLY 15(3):97- 100, 19 79
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TABLE 1

1.
2.
3.
4.
5.
6.

7.

Characteristics of Patients at High Risk for
Postoperative Complications
Advanced age (>65)
Obesity
Past or present smoker
Mucous hypersecretion
Abdominal operation
Postoperative FEV 1 < 1.02
C0 2 > 46 torr

is called upon to meet greater demands at a
time when it is temporarily impaired . These
pathophysiologic events result in a small risk of
complication in normal patients and a much
greater risk in patients with preexisting pulmonary disease.

Factors Predisposing to Postoperative
Complications
Table 1 lists characteristics which predispose patients to postoperative complications. 2 Elderly patients have smaller lung volumes and flow rates. Obesity decreases
pulmonary compliance and reduces lung volumes
and arterial oxygen tensions. Mucous hypersecretion (whether from smoking or other
causes) reduces flow rates and predisposes to
atelectasis and infection . Abdominal operations
have significant effects on lung volumes as
noted above. However, the most important factor contributing to postoperative complications
is chronic obstructive lung disease. The vital capacities and flow rates are low in these patients,
their work of breathing is increased and they are
hypoxemic. In addition, a number of other features in the patient with chronic lung disease
add to the excessive risks for postoperative
complications. These include mucous hypersecretion, abnormal mucociliary clearance
mechanisms, and a propensity toward bronchospasm. In addition, a small percentage of
patients have an elevated arterial carbon dioxide tension indicative of far-advanced pulmonary dysfunction .
Preoperative Evaluation
Preoperative evaluation consists of the
identification of those clinical features, functional abnormalities and operative considerations which are likely to lead to respiratory
complications. Many predisposing factors can
be identified by history and physical examination (age, weight, smoking, dyspnea, cough,
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and other findings) . Similarly, operative factors
such as the site of incision and the expected duration of anesthesia should be identified in consultation with the anesthesiologist and surgeon.
Finally, an objective evaluation of lung volumes,
air flow and gas exchange should be made.
While many pulmonary function tests are available, simple spirometry and arterial blood gas
evaluation are the most readily available and
practical. The level of pulmonary dysfuriction is
best evaluated with the FEV 1 , although other
spirometric tests have been used .3 An FEV 1 less
than one liter per second may be associated
with carbon dioxide retention ; thus, a predicted
postoperative FEV 1 greater than this is desirable. A reasonable estimate of the postoperative FEV 1 can be derived by multiplying
the patient's preoperative value by the decline
expected based upon the location of the operation. As an example, if the patient's preoperative FEV 1 were 2 liters and the contemplated operation were a gastrectomy, one
might expect a 60% reduction in FEV 1 . Thus,
the estimated postoperative FEV 1 would be 800
cc and the patient's risk of respiratory fai lure
high. Arterial blood gas analysis identifies patients with preexisting carbon dioxide retention
and serves as a guide to oxygen supplementation.

Preventive Measures
Identification of patients at high risk is useful only if measures are available which may
prevent complications. Fortunately, specific preand postoperative maneuvers in the high-risk
patient have reduced the incidence of postoperative complications from 66% to 21 % .4 A
treatment program outline for preoperative, intraoperative, and postoperative care is presented in Table 2. For convenience, patients
with COPD have been divided into four groups
according to certain general characteristics;
however, individual patients may fit into more
than one category thus requiring more complex
treatments as suggested in each specific category.
The first group includes patients with obstructive defects and also patients whose venti Ia tory capacities are reduced from other
causes such as restrictive defects, advancing
age, obesity, or other factors. Patient education
is very important; a knowledgeable patient is
more likely to cooperate with difficult or uncom-
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GROUP 1

TABLE 2
Prevention of Postoperative Pulmonary Complications
COPD
GROUP 3
GROUP 2

OBSTRUCTED

PRE OP

HYPERSECRETION

Instruction
Minimize premedication

INTRAOP

Mobilize early

POSTOP lnspirometer

BRONCHOSPASTIC

GROUP 4

C0 2

RETENTION

Stop smoking
Percussion and drainage
Hydration
Antibiotics ?

Stop smoking
Bronchodilators,
aminophylline
Beta agents, steroids

Treat cor pulmonale
Correct metabolic alkalosis

PM operation

Maintain bronchodilators

Insert arterial line
Monitor arterial blood gases
Avoid overventilation

Continue preop program
Sputum smears

Maintain bronchodilators

Continue ventilator
Maintain arterial blood gases
ICU

Supplemental 0 2
Care medication

fortable postoperative maneuvers aimed at protecting the respiratory system. Respiratory therapists can be employed to teach deep
breathing maneuvers and coughing techniques.
The patient can be instructed in the use of an inspirometer, a device ~o ~ncourage maximum
deep inspirations. Preoperative medications
should be minimized; narcotics , benzodiazepams and other sedative drugs reduce
respiratory drive and result in the unvarying respiratory pattern which may lead to alveolar and
airway collapse, a fall in compliance and arterial
hypoxemia. The patient should be encouraged
to sit and walk as soon as possible postoperatively and the inspirometer should be
used frequently. Suppl~mental oxygen should
be administered until the patient has demonstrated the ability to IT]fl.intain normal arterial oxygen tensions breathing room air. In addition,
postoperative medications which could potentially suppress respiration should be given judiciously.
Those patients with mucous hypersecretion constitut~ woup 2. The major postoperative respiratory complication in this group
is atelectasis. Cessation of smoking will significantly reduce the amount of bronchial secretions. The duration of abstinence necessary for
a significant change in the volume of secretions
is highly variable; however, a period of five to
seven days is usually sufficient. Every effort
should be made to provide sufficient time prior
to an operative procedure for clearing of the airways. Chest percussion and postural drainage
accelerate the clearing process, and hydration
aids in liquefying and mobilizing secretions from
the tracheobronchial tree. 5 Gram stains or cul-

ture of tracheobronchial secretions may reveal
pathogenic organisms which should be treated
with appropriate antibiotics. Operations should
be scheduled for the afternoon; the morning is
used in a vigorous attempt to remove any secretions which may have accumulated during the
preceding night. In the postoperative period ,
good tracheobronchial toilet should be maintained . In addition , sputum smears should be
evaluated on a regular basis to guide antibiotic
usage.
Patients with bronchospasm (group 3)
should also stop smoking, as cigarette smoke
alone or in consort with other stimuli often induces bronchospasm. Bronchodilators should
be administered preoperatively in therapeutic
doses. Aminophylline and beta adrenergic
agents are first-line drugs. Systemic steroids
may be necessary in patients who have required their use in the past. Steroids must be
given in those patients who require them on a
routine basis for adequate bronchodilatation.
Patients in group 4 are those whose preoperative arterial carbon dioxide tensions are
elevated and those who are likely to develop
elevations because of the expected decline in
their pulmonary function following surgery. Because the etiology of the respiratory failure is
known (surgery) and improvement likely, the
episodes should be managed with little difficulty. Preoperatively, cor pulmonale should be
treated with diuretics and the administration of
supplemental oxygen to correct pulmonary hypertension and relieve right heart failure. Diuretic and steroid administration may produce
metabolic alkalosis which should be corrected
since it depresses respiratory drive. During the

FAIRMAN : CARE OF PULMONARY PATIENTS FOR NONTHORACIC SURGERY/

99

intraoperative period, an arterial line should be
inserted for repeated measurements of arterial
blood gases. The physician can then make appropriate changes in the ventilator settings to
maintain adequate levels of arterial oxygen tension and baseline levels of arterial carbon dioxide. In particular, intraoperative hyperventilation
should be avoided, as it leads to relative hypoventilation in the postoperative period as body
tissue stores of carbon dioxide are replaced . In
the postoperative period, ventilatory support
should continue until the patient has demonstrated the ability to maintain his own ventilation. This type of care is given preferably in an
intensive care unit where acute exacerbations
of chronic respiratory failure are best managed.

tions. In addition, patients who in previous years
might have been considered "too sick" for operation can now be managed through a postoperative period without significant morbidity
and/or mortality. 6 ....

Conclusions
The patient evaluation and respiratory
care program outlined here provides a measure
of protection for patients with preoperative pulmonary dysfunction. Such a program can be instituted with equipment now available and little
added time, and if done routinely and diligently,
leads to a reduction in postoperative complica-

4. STEIN M, CASSARA EL: Preoperative pulmonary evaluation and therapy for surgery patients. JAMA 211 :787-

1 00 /

FAIRMAN

~

REFERENCES
1. REHDER K, SESSLER A, MARSH HM: General anesthesia
and the lung. Am Rev Resp Dis 112:541-563, 1975.

2. T1s1 GM: Preoperative evaluation of pulmonary function:
Validity, indications, and benefits. Am Rev Resp Dis

119:293-310, 1979.
3. STEIN M, KOOTA GM, SIMON M, ET AL: Pulmonary evaluation of surgical patients. JAMA 181 765-770, 1962.

790, 1970.
5. DOHI S, GOLD Ml: Comparison of two methods of postoperative respiratory care. Chest 73:592-595, 1978.
6. MILLEDGE JS, NUNN JF: Criteria of fitness for anaesthesia
in patients with chronic obstructive lung disease. Brit
Med J 3 670-673, 1975.

CARE OF PULMONARY PATIENTS FOR NONTHORACIC SURGERY

Pulmonary Rehabilitation in a Community
Hospital
RAYMOND J. CASCIARI, M.D.
PATRICIA FERGUSON, R.N .
Pulmonary Rehabilitation , St. Joseph Hospital, 1100 West Stewart Drive, Orange, California

Pulmonary rehabilitation programs seem
to have come into vogue along with the national
craze for exercise . This paper will discuss the
feasibility of a rehabilitation program in a community hospital. In order to do that, we will first
address several questions: "Does pulmonary
rehabilitation really work?" ; " If so, how? "; and
" Is it safe?" Having answered those questions,
we will discuss some of the details of setting up
a rehabilitation program .

"Does Pulmonary Rehabilitation Really
Work?"
Several investigators have shown significant improvement in exercise tolerance following pulmonary rehabilitation programs consisting of a number of treatment modalities
which include bronchodilator therapy, antibiotic
therapy , oxygen, postural drainage, somatic
(exercise) reconditioning, and breathing retraining.1 -4 Petty et al 5 showed not only an increased
exercise tolerance but also improved survival,
reduction in hospital days and improved psychological status in patients completing a rehabilitation program. Pierce and associates 6 have
shown that , following exercise training, maximal
oxygen consumption was higher and, at any
given level of exercise , minute ventilation, oxygen consumption and heart rate were .lower
even though there was no improvement in ventilatory function or lung volumes . Others have
confirmed the beneficial effects of reconditioning without breathing retraining. 7 - 11
Correspondence and reprint requests to Dr. Raymond
J . Casciari, 1201 West Laveta , Suite 608, Orange, CA
92668.

Although there is general agreement that
exercise reconditioning is effective, even in patients with severe chronic obstructive pulmonary
disease, there is no consensus regarding the
value of breathing retraining. The studies appearing in the literature consist of several treatment modalities applied simultaneously; thus it
is impossible to separate the relative effects of
breathing retraining . Pursed lip breathing and
abdominal augmentation can affect a decrease
in minute ventilation and respiratory rate and an
increase in tidal volume as well as an improvement in blood gas tensions .12- 14 Motley 15 found
that slow deep breathing led to a reduction in
the ratio of dead space to tidal volume and an
increase in the oxygen saturation in most patients with emphysema. Following a program of
breathing retraining, Sinclair reported a reduction of inefficient spinal and shoulder girdle
movement during respiration . 16
At the University of California at Irvine we
have recently completed a study that was designed to separate the relative effects of somatic reconditioning and breathing retraining .
Results of this study have been submitted elsewhere for publication. Our program was divided
into four phases : selection of patients, optimizing medical therapy, somatic reconditioning,
and breathing retraining. Eleven patients with
severe type A chronic obstructive pulmonary
disease were selected for this study . Optimal
medical management using bronchodilators,
oxygen, diuretics and ionotropics where appropriate was achieved and stabilized prior to entering the study. The patients were then exercised on a treadmill on an outpatient basis three
times weekly in pairs with one patient resting
MCV QUARTERLY 15(3):101-106, 1979
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Fig 1-Mean percent change in maximal exercise tolerance for all 11 patients over the entire study period. Time
mined to be the point at which breathing retraining has begun .

while the other was exercising . The total exercise session for two men would last one hour
with each man exercising for approximately 25
minutes. Each exercise session consisted of a
warm-up period at slow speeds! a stress period
during which the patient would be encouraged
to top his previous maximal tolerance, rest, and
then several longer exercise periods at lower
workloads. The rest periods were long enough
to let the patient's pulse and respiratory rate return to baseline levels. The patients continued
exercising until their maximal exercise tolerance
was stable for at least four consecutive sessions.
After the somatic reconditioning phase of
the program was completed, a program of
breathing retraining was begun. Breathing retraining consisted of education about chronic
obstructive lung disease, pursed lip breathing, 1 2 · 1 3 expiratory abdominal augmentation , 14
synchronization of movement of the abdomen
and thorax using magnetometry and biofeed-
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back, relaxation techniques for the accessory
muscles 1 7 using electromyography and biofeedback, and psychological reassurance. Attempts
were made to teach the patients to integrate
these breathing retraining techniques into their
activities of daily living . Breathing retraining was
continued until all the techniques were well
learned and were used without prompting during exercise as well as at rest.
There was significant improvement in exercise tolerance with somatic reconditioning
alone (Fig 1 ). The average percent improvement in estimated oxygen consumption, which
is a measure of work tolerance, after somatic
reconditioning was 71 % [0.97 ± 0.41 liters/
min to 1 .52 ± 0.43 liters/min (p < 0 .005)].
What was surprising, however, was that there
was an additional 39% increase in exercise tolerance after breathing retraining [1 .52 ± 0 .43
liters/min to 2.12 ± 0.61 liters/min (p <
O. O2 5 )]. The patients differed in their response
to the program . Some improved minimally after
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exercise reconditioning but markedly after
breathing retraining. Others improved more after exercise reconditioning. The mean improvement from baseline levels after completion of
the program was 1 26%. These results indicate
that somatic reconditioning and breathing retraining are beneficial aspects of a program of
pulmonary rehabilitation.

"If So, How?"
Based upon earlier work, the improvement after exercise reconditioning was expected. It is generally accepted that this improvement is due to a combination of improved
neuromuscular coordination and acclimatization
to walking on a treadmill, improved utilization
and distribution of delivered oxygen, and improved effort due to motivational factors . 1 5 .7. 9
The improvement after breathing retraining is more difficult to explain and has not been
previously reported in the literature; it could not
be attributed to any improvement in resting pulmonary function since none was found. Most
previous workers have not found any change in
resting pulmonary function 1 · 6 - 8 following a program of pulmonary rehabilitation, and our study
substantiated these findings.
Arterial blood gas studies showed that the
Pa0 2 did increase significantly from the reconditioning to the retraining phase . This indicates
better ventilation-perfusion relationships following breathing retraining . We could not, however, attribute the improvement observed in exercise tolerance to this increase in Pa0 2 alone,
since the improvement in oxygen content would
not be great enough to account for the improvement in exercise tolerance. Arterial blood gas
studies also showed that there was a significant
decrease in the base excess after breathing retraining compared to both the baseline period
and the reconditioning period. This indicates
that the patients were willing to exercise beyond
their anaerobic threshold following breathing retraining. This would increase exercise tolerance; however, it is again unlikely that this
would account for all the improvement we observed .
The heart rate did not change significantly
during the study (Fig 2). However, the respiratory rate decreased significantly following
breathing retraining both at rest and after maximal exercise. When examined further it became
apparent that the decrease in respiratory rate
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Fig 2-Heart rate and respiratory rate at rest and after maximal exercise measured at the beginning of the study, after
somatic reconditioning and after breathing retraining.

was due to an increase in tidal volume, because
minute ventilation did not change significantly.
Cherniack 18 has shown that there is a decreased efficiency of the respiratory muscles
and a high oxygen cost of increased ventilation
in patients with emphysema. It has been suggested that breathing retraining may decrease
the work of breathing by lowering the respiratory rate and relaxing accessory muscles. 1 · 1 6
The most likely explanation for the improvement
demonstrated by our study after breathing retraining is increased efficiency of the respiratory
muscles so that there is less relative increase in
the oxygen cost of increasing ventilation during
exercise, thereby freeing more oxygen for distribution to the peripheral tissues.
This study also showed that sophisticated
and expensive magnetometry monitoring is not
necessary for the purpose of synchronizing
chest and abdominal movement. We found that
patients corrected their own phase lag following
somatic reconditioning and that the magnetometry and biofeedback techniques were not
needed .
Ten of the 11 patients responded to a
questionaire that was sent to them at the conclusion of the study. All felt that they had benefited from the study (8 answered " very much"
and 2 answered " a lot"). Their comments regarding how they benefited are interesting . In
response to the question "What can you do
now that you could not do before the program?'' two persons said that they could re-
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sume work, two said they were able to travel
(one having completed a cross-country trip) ,
one began to play golf again, one reported the
ability to shop for himself, and one related he
TABLE
Comprehensive Respiratory Care: Factors to Consider
I. General
A. Environmental factors
1 . avoid inhalation of pollutants, including cigarette smoke
2. avo id occupational hazards
3. consider climate (altitude, temperature , humidity , smog)
B. High fluid intake, unless contraind icated by presence of cardiac disease
C. Yearly influenza shot
D. Pneumococcal vaccine shot
II. Medications
A. Bronchodilators
1 sympathom imetics (prefer beta 2 stimulators)
2. theophylli ne types
B. Expectorants
1. water
2 . glyceryl guaiacolate
3. other
C Antim icrobials (earl y antibiotic therapy for pulmonary infections)
D. Corticosteroids
E. Dig italis
F. Diuretics
G. Cromolyn sodi um
H. Other
Ill. Respiratory Therapy
A. Aerosol devices
1 . cartridge inhaler
2. hand-held nebulizer
3. compressor-driven nebulizer
4 . Intermittent positive pressure breathing
B. Humidification devices
1 . vaporizer / humidifier
2. al l-purpose nebulizer (heated or cool mist)
3. ultrasonic nebulizer
C Oxygen systems
1 . high-pressure gas cylinders (stationary or portable)
2. low-pressure liquid systems (stationary or portable)
3. concentrators
D. Air purifiers
IV . Physical Therapy
A Somatic (exercise) reconditioning
B . Breath ing retraining
C. Percussion and postural drainage
V. Occupational Therapy
A. Activities of daily living
B . Energy conservation
C. Adaptive equipment
VI. Nutrition
VII. Psychosocial Evaluation and Recommendations for
Vocational Rehabi litation
VIII. Patient and Family Education
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was able to walk up a small hill to a recreation
center that he had not been able to climb for the
previous three years. Four patients suggested
that the most important benefit of the program
was learning that they could recover from a
stressful situation, thereby decreasing their
sense of panic. These findings , suggestive of
subjective improvement, are similar to almost
every study of pulmonary rehabilitation that has
appeared in the literature . 1 · 4 .7 10 This improvement may be secondary to the physiologic
changes already described , or it may represent
benefits obtained by the patients from the
amount of attention rendered to them by members of the rehabilitation team . In any event, it
seems to be a real and consistent finding following programs of pulmonary rehabilitation .

"Is It Safe?"
No complications of exercise were observed in our study; indeed , not a single study
has reported deterioration of cardiopulmonary
function following a program of pulmonary rehabilitation . There has been no precipitation of
right cardiac failure ; to the contrary , a fall in
mean resting pulmonary artery pressure along
with a rise in arterial oxygen partial pressure has
been reported . 19
How to Set Up a Program in a Community
Hospital
Equipment and Physical Plan
Approximately 400 sq ft is needed to
house a rehabilitation program, one easily accessible from a hospital entrance or the parking
area. The room should be divided so that there
is an area where patients can exercise and an
area where the physician can examine prospective patients. Since patients will be exercising
rather strenuously , the room must be well ventilated .
We elected to use a treadmill to recondition our patients . We chose this because treadmill walking more closely approximates day to
day activity than bicycle ergometry. A cardiac
monitoring system, complete with recorder, is
mandatory , as is a fully equipped resuscitation
cart. Oxygen is , of course, available and we try
to have several different types on hand to instruct the patients in their use. A Hewlett-Packard ear oximeter is an excellent way of measuring oxygen saturation noninvasively .20 This
essentially negates the need for arterial line
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monitoring. The ear oximeter attaches to the
patient's ear and gives continuous saturation
readouts at rest, while exercising and during recovery. All of the equipment described above
can be obtained for less than $15,000.
Personnel
The rehabilitation team consists of a medical director, a rehabilitation specialist who may
be a registered nurse, a respiratory therapist or
a physical therapist, a social worker, and in
some instances an occupational therapist and a
psychologist. The medical director performs a
complete history and physical on all candidates
referred to the program. He also supervises and
interprets the exercise stress test and the pulmonary function tests, and documents the degree of the patient's disability. A useful checklist
illustrating the comprehensive approach to the
patient with chronic obstructive pulmonary disease is shown in the Table. Various aspects of
this program can be implemented by the physician directly; however, many aspects, including
techniques of avoidance of cigarette smoke,
nutritional information and family education, are
better performed by other members of the rehabilitation team . The physician sees the patient at
the conclusion of the program and at scheduled
follow-up sessions at 6 weeks, 6 months, 1 2
months, 1 8 months and 24 months after completion of the program.
Pulmonary Stress Testing
Stress testing can be performed on either
a bicycle ergometer or on a treadmill. Cardiac
status and oxygen saturation are monitored
continuously. The test consists of graded exercise with the patient walking at each level for
three minutes. Since most of our patients have
severe exercise limitation, we have arbitrarily
elected to begin our stress testing at much
lower workloads than the accepted protocols
for cardiac disease. The patient is started at 1
mph and a 0% grade for three minutes. The
speed is then increased by 1 mph every three
minutes until the patient reaches 3 mph at a 0%
grade for three minutes at which point the grade
is increased to 6%. The grade is then increased
by 2% increments every three minutes until the
patient reaches his maximal exercise tolerance.
The patient is then allowed to recover until his
heart rate and respiratory rate have returned to
baseline levels. If the patient's saturation falls

below 88%, the test is repeated with oxygen in
place administered by nasal cannula and
started at 2 liters/ min. The stress test is repeated, increasing the oxygen by increments of
1 liter /min , until the patient's saturation remains above 88% at maximal exercise.
The typical patient with severe chronic ob. structive pulmonary disease will stop exercising
at a heart rate that is well below his predicted
maximum. Additionally , he will show some
desaturation with respect to oxygen . If the patient stops exercising when his heart rate has
reached his predicted maximum, one must consider either primary cardiac disease or extreme
deconditioning as the cause of the patient's exercise limitation .
The stress test as described above is a
valid indicator of the need for home oxygen . Patients who desaturate severely with maximal exercise are also likely to need oxygen during
sleep and meals. An exact prescription can be
written based on the oxygen saturation as observed during the treadmill stress test.

The Program
Many different types of programs exist.
We feel that six weeks is a reasonable length of
time to accomplish both somatic reconditioning
and breathing retraining. We also favor an outpatient program as opposed to inpatient rehabilitation, as outpatient rehabilitation enables the
patient to incorporate the techniques taught into
his activities of daily living. In addition, there is
more time in a six-week program than in a twoweek inpatient program for problems of day-today living to become apparent to the patient
and the rehabilitation team. Our patients come
to the hospital three times a week for one hour
sessions. Each patient has a partner, and indeed the support of a partner seems to be a
very important part of the psychological reassurance. Somatic reconditioning and breathing
retraining are begun simultaneously and are enforced throughout the program. Breathing retraining emphasizes primarily pursed lip breathing, accessory muscle relaxation , abdominal
augmentation and psychological reassurance.
The program is tailored to the individual patient
utilizing the expertise of physical therapy, occupational therapy and social services as indicated by the weekly reviews of each patient's
case.
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In conclusion, rehabilitation has been
shown to be an effective and safe art of medical
practice that can return a patient to his highest
possible functional capacity. Pulmonary rehabilitation programs should include careful and optimal medical management, somatic reconditioning, and breathing retraining which can be
performed in a community hospital without expensive or invasive monitoring. If properly carried out, such programs will result in increased
exercise tolerance, improved sense of well
being, and reduced hospitalization.
Acknowledgments: We wish to thank
Jackie Gardiner for her assistance in typing this
manuscript.
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Newer Drugs and Their Use in the
Treatment of Bronchial Asthma
ORHAN MUREN, M.D.
Professor of Medicine, Medical College of Virginia, Health Sciences Division of Virginia
Commonwealth University, Richmond, Virginia

The current knowledge of pathophysiology and new medications, as well as the
better use of old ones, has significantly improved the therapy and prognosis of patients
with bronchial asthma. However, it should be
understood that drug therapy is beneficial only
when aggravating or precipitating agents have
been eliminated from the patient's environment;
these include allergens, such as dust, mold,
pollens and other irritants, infection, exercise,
psychological disturbances, certain drugs (aspirin}, and stimulation of irritant receptors in the
respiratory tract.
There are five major classes of drugs used
in treating bronchial asthma: ( 1) adrenergic
agents, (2) xanthines, (3) corticosteroids, (4)
cromolyn sodium, and (5) parasympatholytic
agents. Some adrenergic agents, such as terbutaline and metaproterenol, offer advantages
over others, such as epinephrine , isoproterenol
and ephedrine . Among the xanthines the measurement of theophylline blood levels has resulted in the more effective use of aminophylline
and other theophylline compounds. The development of a topical steroid, beclomethasone,
has been useful in treating steroid-dependent
chronic asthmatics. The drugs described below
are prescribed to eliminate wheezing and dyspnea; however, other types of therapy such as
antibiotics for infections, hyposensitization for
allergic factors, and counseling for emotional
disturbances should also be considered.
Correspondence and reprint requests to Dr. Orhan
Muren, Box 4 72, Medical College of Virginia, Richmond,
VA 23298.

Adrenergic Drugs

Adrenergic agents reduce bronchial obstruction by activating the enzyme adenylcyclase, which increases cyclic adenosine monophosphate (cAMP) in bronchial smooth muscle
and mast cells. Adrenergic drugs have alphaand beta-stimulating effects. The stimulation of
alpha receptors causes vasoconstriction. Beta
receptors are divided into beta, and beta2 receptors. The stimulation of beta , receptors
causes cardiac stimulation; stimulation of beta 2
receptors is responsible for bronchodilatation,
as well as other effects. Terbutaline and metaproterenol are primarily " beta2 -selective," but
they also stimulate the heart minimally.
Terbutaline (Brethine; Bricanyl}, which
comes i·n tablets and ampules is, as noted
above, a selective beta2 agent. The most common side effect is tremor, which is caused by
stimulation of beta2 receptors in the skeletal
muscle. It is recommended that this drug be
started at 2.5 mg every eight hours. Tremor
may disappear after continuation of the medication; thereafter the dose can be increased to 5
mg every eight hours. However, it should be
kept in mind that an injection dose of 0 .25 mg
of terbutaline may also cause a significant degree of cardiac stimulation.
Metaproterenol (Alupent) is available as
a syrup, in tablets and as an aerosol; tremor is a
common side effect. The usual oral dose is 1 0
to 20 mg q.8.h.
lsoetharine (Bronkosol; Bronkometer) is
available as an aerosol.
Epinephrine and isoproterenol have
been used for a long time in the management of
MCV QUARTERLY 15(3):107- 110, 1979
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patients with bronchial asthma. Epinephrine has
both alpha- and beta 1- and beta 2 -stimulating effects. lsoproterenol stimulates both beta 1 and
beta 2 receptors. Epinephrine may also improve
symptoms by constricting vessels in the bronchial mucosa, thus decreasing edema. However, epinephrine increases blood pressure,
and large doses of this agent or isoproterenol
can cause angina pectoris and cardiac arrythmias. It has been observed that cardiac
stimulation may increase blood flow in some regions of the lung where there may be poor ventilation. This may cause lowering of arterial 0 2
tension.
Ephedrine. This drug was the first adrenergic agent used and it stimulates both alpha
and beta receptors. However, its bronchodilatation activity is less than that of the new beta 2
agents. Ephedrine may increase blood pressure
and may cause CNS stimulation (insomnia, nervousness). It may be responsible for urinary retention in patients with some degree of prostatic
obstruction. Ephedrine and isoproterenol have
more beta- 1 (cardiac stimulation) than the newer
medications . Insomnia, palpitations, and anxiety limit their use in bronchial asthma .

Xanthines
Theophylline is 1 ,3 dimethylxanthine.
Methylxanthines increase intracellular cAMP by
inhibiting phosphodiesterases , enzymes responsible for the breakdown of cAMP. Theophylline has been used for many years in combination with ephedrine and a sedative. The
combination medications provide one fourth to
one half the proper dose of theophylline and
less bronchodilatation.
Aminophylline is theophylline ethylenediamine and is used more often than theophylline itself. Since the difference between
therapeutic and toxic doses of theophylline
compounds may be narrow, it is desirable to
start with a small dose and increase it as required . Plasma theophylline levels should be
obtained if patients do not respond to the usual
doses; the optimum serum level is between 1 0
and 20 µg / ml. 1 Patients with chronic liver disease should be treated carefully, since theophylline is detoxified in the liver. Serum theophylline levels greater than 20 µg/ml are
usually associated with toxic side effects, such
as nausea, vomiting, anorexia, headache, tachycardia and CNS irritation . Levels greater than
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30 to 40 µg / ml may lead to serious cardiac arrythmias and seizures .
An oral loading dose of approximately 5
to 6 mg/kg of aminophylline, anhydrous theophylline, or elixophylline will supply therapeutic
theophylline levels within 30 to 45 minutes and
will usually be effective against a mild-to-moderate degree of bronchospasm. In cases of severe bronchospasm 6 mg/kg aminophylline
should be given intravenously in a drip over 20
minutes.
The usual recommended intravenous (IV)
maintenance of theophylline is 0 .9 mg/kg/hr
aminophylline . Serum theophylline levels should
be checked at 1 8 to 24 hours and proper adjustments made as needed . In patients with
congestive heart failure or liver disease, the
dose should be reduced by half or more if indicated. In elderly people intravenous maintenance of theophylline is 0. 7 mg/kg/hr.
For long-term maintenance of theophylline
an average-size adult patient with bronchial
asthma requires approximately 800 to 1 200
mg/day aminophylline. The serum levels
should be checked after three days on this therapy, and proper adjustments should be made to
maintain levels between 1 0 to 20 µg/ml. The
slow-release preparations of theophylline can
be given every 1 2 hours and can be effective
against early-morning bronchospasm .

Corticosteroids
Steroids are very useful in the treatment of
asthma but should be used only when conventional bronchodilating agents fail to relieve bronchospasm. Some of the undesirable side effects
of steroids include acne, peptic ulcer, osteoporosis , growth retardation , hypertension, adrenal suppression and opportunistic infections.
The exact mechanism of steroid action in
asthma is not definitely known . Large doses appear to potentiate beta agonists and cause
bronchodilatation. As soon as symptoms are relieved with up to 60 to 80 mg/day of prednisone or prednisolone , the dose is tapered to the
smallest effective dose , 5 to 1 0 mg/day or 1 0
to 20 mg every other day.
Beclomethasone dipropionate (Vanceril) is a topically active , inhaled steroid (50
µg/puff , 8 to 20 puffs per day). When used
properly it has no, or only minimal, systemic effects and is especially useful in steroid-dependent chronic asthmatics. It is most effective
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when the patient is relatively free of asthma .
The usual dose is two puffs four times a day.
The patient continues to take all previous medications . If the patient improves after two weeks,
steroids should be decreased slowly. If no improvement takes place, the dosage may be increased to four puffs four times a day and then
decreased after two weeks of symptomatic improvement. Sixteen hundred micrograms or
greater per day causes adrenal suppression . By
pro per administration of beclomethasone in
many steroid-dependent asthmatics , the steroid
dose can be significantly reduced and even discontinued . The main possible adverse effects of
this agent are nasopharyngeal candidiasis and,
in patients who have been on long-term systemic steroids, adrenocortical insufficiency as
adrenal suppressive doses of corticosteroids
are decreased . Oral candidiasis can be minimized by rinsing the oral cavity after each use
with plain water ; if candidiasis occurs, nystatin
(Mycostatin) rinse three times a day will eradicate the infection .

Cromolyn Sodium
Cromolyn blocks the release of chemical
mediators from the sensitized mast cells; it has
no antihistamine, bronchodilator or anti-inflammatory characteristics and should not be used
during an acute asthmatic attack. It has only
prophylactic value . The main indication in the
asthmatic appears to be as a steroid-sparing
agent. It is most useful in young patients with
extrinsic or exercise-induced asthma. The usual
dose is 20 mg four times a day by a special inhaler. 2 If after four weeks of therapy, no improvement occurs, the drug should be disconti nued . The adverse side effects include cough,
th roat irritation, skin rashes, occasionally bronchospasm, and eosinophilic pneumonia .
Parasympatholytic Agents
A parasympatholytic agent, such as ipratropium (SCH-1 000/ Atrovent , 40 µg/puff) may
give bronchodilatation in asthma and chronic
bronc hitis. It is not available in the United States
at the present time .
Combination of Drugs
A beta agonist such as terbutaline can be
given with theophylline, and lower doses of the
two together may be as effective or less toxic
th an higher doses of either drug alone . Oral

bronchodilating agents are usually continued
when patients receive corticosteroids or cromolyn sodium .

Indications of Severity of Bronchial Asthma
Significant reduction in FEV 1 (less than
1 . 0 liter) associated with one or more abnormalities such as marked scalene muscle contractions, mental confusion , pulse rate greater
than 130/min, pulsus paradoxus greater than
1 0 mm Hg , marked overdistension of the
lungs on chest x-ray, central cyanosis, arterial
PC02 greater than 40 mm Hg, pneumothorax ,
or pneumomediastinum , indicate a severe attack of asthma .3 If FEV 1 is less than 25% predicted, there is a tendency to C0 2 retention .
Pulsus paradoxus of more than 1 0 torr is associated with FEV1 less than 25% predicted ; scalene muscle contractions and intercostal retractions suggest FEV 1 less than 1 .0 liter.4
Patients with these abnormalities should
be hospitalized immediately, and receive proper
therapy (IV aminophylline, high doses of steroids, supportive and specific care) .
Status asthmaticus is defined as a severe
asthma attack unresponsive to inhaled or injected sympathomimetic amines. The cornerstone of management of status asthmaticus is
the administration of IV aminophylline and large
doses of corticosteroids . Supportive care and
specific therapy for any complication should
also be undertaken.
Indications for Intubation and Mechanical
Ventilation in Asthma.
1 . Arterial PC0 2 over 50 to 60 torr in the
absence of chronic hypercapnea.
2. An arterial P0 2 under 60 torr on 6 liters of 0 2 by nasal cannula .
3 . Evidence of marked increase in the
work of breathing judged by physical
examination, even in the presence of
near-normal arterial gas studies.
4. Respiratory arrest.
It should be emphasized that during the
acute episode of an asthma attack, there is a
lowering of arterial P0 2 and PC0 2 . Perfectly
normal PC0 2 such as 40 torr indicates fatigue
of the patient and the necessity of aggressive
therapy .
Treatment Failures
Patient compliance and understanding are
important for the successful management of
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asthma. Hidden environmental hazards should
be eliminated. Not every wheezing represents
bronchial asthma; left-sided heart failure ,
chronic obstructive pulmonary disease, pulmonary emboli, hypersensitivity pneumonitis, mediastinal node compression, foreign body in a
large bronchus, or bronchial carcinoid can be
responsible for diffuse wheezing masquerading
as asthma. Finally, inadequate medication may
be the cause of failure to improve. Readings of
serum theophylline at the level obtained one
hour after a dose has been given, and one hour
before the next dose , are helpful indications of
whether an adequate amount has been given
There is a tendency to underuse corticosteroids
in severe acute respiratory failure . It is better to
overuse the steroids for a short period than to

have the patient suffer cardiac, respiratory or
neurologic damage if complications arise.
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Program for the Thirty-Second Annual Stoneburner Lecture Series

New Concepts in Outpatient Management of Chronic Obstructive Pulmonary Disease and
Asthma
Presented by
the Pulmonary Division and the Department of Continuing Medical Education
Friday, April 6, 1979
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Pathophysiologic Concepts in COPD
FREDERICK L. GLAUSER, M.D.

Does Pulmonary Rehabilitation Really Work?

Pathophysiologic Concepts in Acute Bronchial
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RAYMOND CASCIARI, M.D.
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Newer Drugs and Their Use in the Treatment of
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JAMES P . BAKER, M.D.
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Preoperative Evaluation of Patients with COPD
and Asthma
PAUL FAIRMAN, M .D.
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Outpatient Management of COPD in
Asthma
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INTRODUCTION
The 32nd Stoneburner Lecture Series,
''New Concepts in the Outpatient Management
of Chronic Obstructive Pulmonary Disease and
Asthma, " was presented on April 6 and 7,
1979 , to an audience consisting principally of
family practitioners and internists. The conference explored new concepts about COPD and
asthma which have emerged from basic and
clinical research during the last decade . In particular, practical management related to drug
treatment , pulmonary rehabilitation , pulmonary
function testing, pre- and postoperative care ,
and the use of oxygen were emphasized .
James P. Baker, M. D., Chairman , Department of Medicine, Eastern Virginia School
of Medicine, and a former member of the Pulmonary Division at the Medical College of Virginia, was the Stoneburner Lecturer. He reviewed and updated the modern outpatient
management of chronic obstructive pulmonary
disease. Raymond Casciari , M.D., Director of

the Rehabilitation Center, St. Joseph's Hospital ,
Anaheim, California, and Clinical Instructor of
Medicine at the University of California, Irvine,
talked about his experience in establishing a
pulmonary rehabilitation program in a community hospital. In addition, Dr. Casciari stressed
the physiological benefits derived from rehabilitation.
The Medical College of Virginia Pulmonary faculty and selected pulmonary fellows actively participated in the preparation of the lectures . The audience 's response was excellent
as evidenced by the many questions asked and
the excellent post-program evaluation .
The Pulmonary Division would like to
thank the Department of Continuing Medical
Education for planning this symposium .
FREDERICK L. GLAUSER , M.D.
Associate Professor and Chief,
Pulmonary Division
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